SELP and type 2 diabetes mellitus: CAD patients with known T2D (n = 242) had increased levels of platelet aggregation compared with non-diabetic CAD patients (n = 623) evaluated by AA- (183 (111; 279) vs 143 (86; 219) AUC, p<0.0001) and collagen-induced platelet aggregation (292 (185; 442) vs 264 (173; 381) AUC, p<0.01) and the VerifyNow Aspirin (446 ± 43 vs 432 ± 35 ARU, p<0.0001) and increased levels of platelet activation evaluated by soluble P-selectin (79 ±26 vs 72 ±25 ng/mL, p<0.001).